Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

China flag China · Delayed Price · Currency is CNY
15.64
+0.13 (0.84%)
At close: Dec 5, 2025
-15.96%
Market Cap 17.47B
Revenue (ttm) 2.70B
Net Income (ttm) -100.29M
Shares Out 1.12B
EPS (ttm) -0.08
PE Ratio n/a
Forward PE 74.76
Dividend 0.09 (0.58%)
Ex-Dividend Date Jun 6, 2025
Volume 7,188,770
Average Volume 11,532,123
Open 15.55
Previous Close 15.51
Day's Range 15.35 - 15.68
52-Week Range 13.10 - 21.12
Beta 1.10
RSI 31.35
Earnings Date Apr 21, 2026

About SHE:300601

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company’s marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed, rabies vaccine (human diploid cell) for human use, hib conjugate vaccine, measles and rubella com... [Read more]

Sector Healthcare
Founded 1992
Employees 1,913
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300601
Full Company Profile

Financial Performance

In 2024, SHE:300601's revenue was 2.65 billion, a decrease of -23.75% compared to the previous year's 3.48 billion. Earnings were 201.65 million, a decrease of -76.59%.

Financial Statements

News

There is no news available yet.